HeyJaredLuis Quevedo
- Indexed articles, last 90 days
- 6
- Latest publication
- Sep 1, 2026
- Outlet visibility, for Medscape
- Top 50K sites
- Earliest in this view
- Jul 23, 2026
Latest articles
Time-Restricted Eating Helps Sustain Weight Loss (opens the original)
Read excerpt
Chrononutrition, the study of how circadian rhythms interact with food, has moved from an experimental conceptto a practical consideration in preventive medicine and weight management. For decades, nutrition advice focused on what to eat: cut calories, reduce saturated fat and added sugars, and increase fiber and fresh foods. Modern research adds an important nuance: The body metabolizes the same nutrients differently at different times of day. Two recent studies illustrate how timing and cultur
EULAR Project Reveals Gaps in European Rheumatology Care (opens the original)
Read excerpt
A new study published in the Annals of the Rheumatic Diseases highlighted substantial disparities across European countries in terms of access to rheumatologists, treatments, and nonpharmacologic care for rheumatic and musculoskeletal diseases (RMDs). The study analyzed data from 36 member countries of the European Alliance of Associations for Rheumatology (EULAR). The primary objective was to establish a longitudinal baseline for monitoring inequalities and assessing progress toward more equita
Cefazolin Matches Penicillins for MSSA Bacteremia (opens the original)
Read excerpt
The international clinical trial published in The New England Journal of Medicine found that cefazolin was noninferior to traditional antistaphylococcal penicillins (ASPs), such as cloxacillin and flucloxacillin, for treating methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia. Cefazolin was also associated with a lower incidence of acute kidney injury. S aureus bacteremia is the leading bacterial cause of infection-attributable mortality worldwide, with more than 1 in 4 affected pat
Biologics and Infection Risk: Time to Rethink Prevention? (opens the original)
Read excerpt
Targeted biologic and targeted synthetic therapies have revolutionized the management of inflammatory and autoimmune diseases, including rheumatoid arthritis, psoriasis, spondyloarthritis, inflammatory bowel disease, and hidradenitis suppurativa. These therapies have achieved unprecedented efficacy and substantially improved patients’ quality of life. However, by modulating key immune pathways, they can cause secondary immunodeficiency, increasing the risk for a broad range of infections. A narr
Urologic Infections: EAU 2026 Guideline Updates (opens the original)
Read excerpt
Urinary tract infections (UTIs) are among the most common bacterial infections encountered in clinical practice. In response to the growing threat of antimicrobial resistance, the European Association of Urology (EAU) has released the 2026 update of the Urological Infections Guidelines, introducing major changes to the classification and management of UTIs while reinforcing the principles of antibiotic stewardship. The updated guidelines synthesize the latest evidence to help clinicians optimize
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 50K sites
For Medscape, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.